Pharmaceutical Transport: Transitioning From Sea To Air

| By: Gregory Tremel

The Problem

According to an an IATA article, pharmaceutical transportation is set to be worth $86 billion in 2019. More than 5%, which is about $15 billion, will relate to cold-chain products.

Unfortunately, a lack of standards in the aviation industry puts it at risk of losing out on its “fair share” of the market. Currently, maritime transport accounts for 7x the amount of pharmaceutical products transported by air.

This is a result of a lack of trust in airlines’ ability to safely and properly handle the transport of vaccines and medicines without risk of denaturation.


The IATA Solution

IATA’s solution was to establish the Center of Excellence for Independent Validators (CEIV), which is designed to offer a “comprehensive solution” that both assists the aviation industry and its regulators.


The Miami International Airport has already constructed a reliable CEIV Pharma Community. In 2017, the airport custom-built a cooling facility equipped with alarm systems, temperature data recorders and 24/7 CCTV monitoring.  

DGD Hazmat is located less than 2 miles from the MIA, making it the perfect 3PL partner for shipping your pharmaceutical goods. Our temperature-controlled containers, trucks and vans ensure that your asset is kept at the optimal temperature at every leg of the shipment.

The IATA Temperature Control Regulations is a guide to enable stakeholders involved in the transport and handling of pharmaceutical product to safely meet the requirements. View full list and more resources here.


Watch the video below for more information about CEIV Pharma